Dr. Kenneth Blum Appointed Editor-in-Chief Of ‘Journal of Addiction Research & Therapy’

TAMPA, Fla. - Sept. 6, 2013 - PRLog -- Austin, Texas: It is with great honor that Dr. Sudhakar Yakkanti, President of Omics Group of San Fransisco, has appointed Kenneth Blum, Msc., PhD, DHL and Rajendra Badgaiyan, MD, MA to the prestigious position of Editor-in-Chief and Co-Editor-in-Chief respectively of the Journal of Addiction Research & Therapy, a medical peer-reviewed publication. Among their responsibilities, doctors Blum and Badgaiyan will have final approval on all papers published in the journal.

The Journal of Addiction Research & Therapy (JART) is a peer-reviewed publication comprised on leading addiction researchers and thinkers. It provides comprehensive aspects of physiological, biochemical, genetic and behavioral pathways underlying addiction, focusing on spectrum of related CNS disorders and novel therapies providing an unprecedented overview of a complex field of high societal significance. JART is an Open Access journal. Its contents are free and available on-line, making the Journal of Addiction Research & Therapy a valuable research and clinical resource.

Both Dr. Blum and Badgaiyan are uniquely qualified for their new positions. Dr. Rajendra Badgaiyan  is an Associate Professor of Psychiatry at the University of Buffalo, Assistant Professor at Harvard University, and is serving as Psychiatrist at WNY VAMC, Buffalo, NY. Dr. Badgaiyan is a distinguished member of various societies including Society of Nuclear Medicine, American Psychiatric Association, Society for Neuroscience and many more. Badgaiyan has a unique background in neuro-imaging methods and is credited with single-cell imaging of dopaminergic pathways.

Dr. Blum made global headlines over twenty-years ago with his co-discovery of the ‘Reward Gene’ and subsequent discovery of ‘Reward Deficiency Syndrome (RDS).’ RDS has recently been added to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). In addition, he has made significant contributions to the discovery and understanding or the ‘Reward Center’ and ‘Reward Circuitry.’ Dr. Blum has over 400 papers published by scientific and medical peer-reviewed publications. He is currently a volunteer Full Professor at the Department of Psychiatry, McKnight Brain Institute, University Of Florida College Of Medicine Gainesville, Florida and Research Professor (Adjunct) at Global Integrated Services Unit, University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT. In 1995 Dr. Blum retired as a full professor in the Department of Pharmacology, University of Texas, where he was also chief of the Division of Addictive Diseases, chief of the Division of Substance and Alcohol Misuse, and director of the Laboratory of Pharmacogenetics at the University of Texas Health Science Center (San Antonio, Texas). Dr. Blum is also the Chief Science Officer at the National Institute For Holistic Addiction Studies in North Miami Beach, Florida.

Dr. Ken Blum is a media pro and available for interviews. Please contact Joe Ullrich, Omni Publicity http://www.omnipublicity.com for additional information or to arrange an interview.

Please visit Dr. Kenneth Blum online at: http://www.rewarddeficiencysyndrome.com/ndx.php

CREDENTIALS: Dr. Kenneth Blum is considered by his peers the "Father of Psychiatric Genetics". He is an adjunct full professor in the Department of Psychiatry, University of Florida College of Medicine, and McKnight Brain Institute (Gainesville, Florida). Dr. Blum is also an honorary professor in the department of psychiatry, University of Vermont, VT, Professor Blum is best known from his study on the genetics of alcoholism published in the Journal of the American Medical Association in1990. Blum is the pioneer of Neuronutrinet therapy for all reward deficiency behaviors, especially addiction.  Working in the fields of neuropsychiatry and genetics, nutritional genetics and pharmacogenetics, Kenneth Blum's research has been recognized through numerous awards. As a former full professor at the Department of Pharmacology, University of Texas, he was also chief of the Division of Addictive Diseases, chief of the Division of Substance and Alcohol Misuse, and director of the Laboratory of Pharmacogenetics at the University of Texas Health Science Center (San Antonio, Texas). Currently, Kenneth Blum is the Chairman of the Board and Chief Scientific Officer of LifeGen Inc (San Diego, California), a nutrigenomic evidence-based corporation; scientific director of Path Foundation NY, Scientific Advisor for Dominion Diagnostics, Inc. Rhode Island; NeuroScience Advisor Malibu Beach Recovery Center; Scientific Officer of G & G Holistic Addiction Treatment Center, North Miami Beach, Florida. He holds numerous patents worldwide, 12 published books and over 500 articles published in peer review journals. He is on13 editorial review boards and is the Editor -in-Chief of the Journal of Genetic Syndromes & Gene Therapy and Co-Editor-in-Chief of the BMC Journal Integarive OMics and Molecular Biology.